Cambridge Investment Research Advisors
CLOV icon

Cambridge Investment Research Advisors’s Clover Health Investments CLOV Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91K Buy
17,426
+1,425
+9% +$4.84K ﹤0.01% 3940
2026
Q1 		$28K Hold
16,001
– – ﹤0.01% 3883
2025
Q4 		$38K Sell
16,001
-2,000
-11% -$5.47K ﹤0.01% 3768
2025
Q3 		$55K Buy
18,001
+740
+4% +$2.11K ﹤0.01% 3649
2025
Q2 		$48K Sell
17,261
-1,250
-7% -$4.11K ﹤0.01% 3540
2025
Q1 		$66K Buy
18,511
+538
+3% +$2.16K ﹤0.01% 3387
2024
Q4 		$57K Buy
17,973
+47
+0.3% +$168 ﹤0.01% 3369
2024
Q3 		$51K Buy
+17,926
New +$41K ﹤0.01% 3332
2024
Q1 		– Sell
-14,099
Closed -$13K – 3323
2023
Q4 		$13K Sell
14,099
-2,096
-13% -$2.06K ﹤0.01% 3158
2023
Q3 		$17K Sell
16,195
-3,728
-19% -$4.43K ﹤0.01% 3089
2023
Q2 		$18K Buy
19,923
+3,503
+21% +$3.11K ﹤0.01% 3130
2023
Q1 		$14K Sell
16,420
-14,640
-47% -$16K ﹤0.01% 3119
2022
Q4 		$29K Sell
31,060
-15,224
-33% -$20.3K ﹤0.01% 3019
2022
Q3 		$79K Sell
46,284
-9,923
-18% -$26K ﹤0.01% 2890
2022
Q2 		$120K Sell
56,207
-1,300
-2% -$3.46K ﹤0.01% 2838
2022
Q1 		$204K Buy
57,507
+7,730
+16% +$22.4K ﹤0.01% 2852
2021
Q4 		$185K Buy
49,777
+18,055
+57% +$111K ﹤0.01% 2910
2021
Q3 		$234K Buy
31,722
+5,695
+22% +$48.7K ﹤0.01% 2668
2021
Q2 		$347K Buy
+26,027
New +$256K ﹤0.01% 2362
2021
Q1 		– Sell
-25,864
Closed -$434K – 2883
2020
Q4 		$434K Sell
25,864
-65,431
-72% -$728K ﹤0.01% 1863
2020
Q3 		$1.14M Buy
+91,295
New +$1.01M 0.01% 1113

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cambridge Investment Research Advisors's CLOV Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Clover Health Investments (CLOV) stake by 8.9% in Q2 2026, buying an estimated $4.84K and bringing the position to 17,426 shares worth $91K. The position accounts for ﹤0.01% of the portfolio, ranked #3940.

Cambridge Investment Research Advisors first reported a position in CLOV in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.14M in Q3 2020. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Cambridge Investment Research Advisors held 17,426 shares of Clover Health Investments worth $91K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,425 Clover Health Investments shares in Q2 2026, an estimated $4.84K.
  • Clover Health Investments made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3940 holding.
  • Cambridge Investment Research Advisors first reported a position in Clover Health Investments in Q3 2020 and has held it in 21 quarters since.
  • Cambridge Investment Research Advisors's Clover Health Investments position peaked at $1.14M in Q3 2020.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.